CureTech (Pidilizumab Drug)

Business Data, Corporate Office and Headquarter Address

About

CureTech (Pidilizumab Drug) is Buildings and Property in Israel that focus on Humanized monoclonal antibody business. They cover business area such as humanize monoclonal antibody, mAb, tumor growth, metastasis, cancer cell.

Business Type

Buildings and Property

Country

Israel

Founded

-

Company Focus

Humanized Monoclonal Antibody

Website

-

Corporate Office and Headquarter Office address:

42 Hayarkon Street
Yavne 81227
Israel

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

humanize monoclonal antibodymAbtumor growthmetastasiscancer cell

* We use standard office opening hours in near CureTech (Pidilizumab Drug)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

CureTech (Pidilizumab Drug) Frequently Asked Questions

What or who is CureTech (Pidilizumab Drug)?

CureTech (Pidilizumab Drug) is Buildings and Property business from Israel that founded in - ( years old in ), CureTech (Pidilizumab Drug) business is focusing on Humanized Monoclonal Antibody.

Where is CureTech (Pidilizumab Drug) headquarter and corporate office address?

CureTech (Pidilizumab Drug) headquarter office and corporate office address is located in 42 Hayarkon Street Yavne 81227 Israel.

Where is CureTech (Pidilizumab Drug) country origins?

CureTech (Pidilizumab Drug) was founded in Israel.

What is Humanized Monoclonal Antibody business focus on?

In , CureTech (Pidilizumab Drug) is currently focus on Humanized monoclonal antibody sector.

Humanized Monoclonal Antibody Business Interest from Google Trend

Above is snippet of Google Trends for "Humanized monoclonal antibody" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with CureTech (Pidilizumab Drug), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.